propranolol has been researched along with 12-hydroxy-5,8,10,14-eicosatetraenoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levine, L; Rigas, A | 1 |
| Apopa, PL; Bala, M; Boutaud, O; Hamm, HE; Holinstat, M; Oates, JA; Vesci, J | 1 |
2 other study(ies) available for propranolol and 12-hydroxy-5,8,10,14-eicosatetraenoic acid
| Article | Year |
|---|---|
Effect of propranolol on arachidonic acid metabolism by cells in culture.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Arachidonic Acid; Arachidonic Acids; Bronchi; Cattle; Cells, Cultured; Dogs; Mice; Propranolol; Prostaglandins; Rats | 1981 |
Protease-activated receptor signaling in platelets activates cytosolic phospholipase A2α differently for cyclooxygenase-1 and 12-lipoxygenase catalysis.
Topics: 1-Butanol; 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonate 12-Lipoxygenase; Arachidonic Acid; Blood Platelets; Calcium; Chromones; Cyclooxygenase 1; Cytosol; Eicosanoids; Enzyme Inhibitors; Group IV Phospholipases A2; Humans; In Vitro Techniques; Morpholines; p38 Mitogen-Activated Protein Kinases; Propranolol; Protein Kinase C; Receptors, Proteinase-Activated; Signal Transduction; Thromboxane A2 | 2011 |